Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil

Olmesartan medoxomil is an angiotensin type II receptor blocker, antihypertensive agent, administered orally. It is highly lipophilic (log P 5.5) and a poorly water-soluble drug with absolute bioavailability of 26%. The poor dissolution rate of water-insoluble drugs is still a major problem confront...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Prajapati, Shailesh T., Bulchandani, Hitesh H., Patel, Dashrath M., Dumaniya, Suresh K., Patel, Chhaganbhai N.
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818897/
https://ncbi.nlm.nih.gov/pubmed/24232077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/870579
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares